Erratum: Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery (Nucleic Acids Research (2011) 39 (7147-7160) DOI: 10.1093/nar/gkr384);Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery

Nucleic Acids Research

Volumn 39, Issue 16, 2011, Pages 7147-7160

  Galla, Melanie ^a   Schambach, Axel ^a   Falk, Christine S ^a   Maetzig, Tobias ^a   Kuehle, Johannes ^a   Lange, Kathrin ^a   Zychlinski, Daniela ^a   Heinz, Niels ^a   Brugman, Martijn H ^b   Göhring, Gudrun ^a   Izsvák, Zsuzsanna ^c,d   Ivics, Zoltán ^c,d   Baum, Christopher ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GEMININ; HISTONE H2AX; MESSENGER RNA; PROTEIN C JUN; PROTEIN P53; RECOMBINASE; SLEEPING BEAUTY; TRANSPOSASE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL DAMAGE; CELL DEATH; CELL STRESS; CONTROLLED STUDY; CYTOTOXICITY; DNA CLEAVAGE; DNA REPAIR; DOSE RESPONSE; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; TRANSCRIPTION REGULATION; VIRAL GENE DELIVERY SYSTEM;

EID: 79959629606     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr1266     Document Type: Erratum

References (44)

1. Ivics, Z., Hackett, P.B., Plasterk, R.H. and Izsvak, Z. (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell, 91, 501-510. (Pubitemid 27508239)
2. Mates, L., Chuah, M.K., Belay, E., Jerchow, B., Manoj, N., Acosta-Sanchez, A., Grzela, D.P., Schmitt, A., Becker, K., Matrai, J. et al. (2009) Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat. Genet., 41, 753-761.
3. Hackett, P.B., Largaespada, D.A. and Cooper, L.J. (2010) A transposon and transposase system for human application. Mol. Ther., 18, 674-683.
4. Dull, T., Zufferey, R., Kelly, M., Mandel, R.J., Nguyen, M., Trono, D. and Naldini, L. (1998) A third-generation lentivirus vector with a conditional packaging system. J. Virol., 72, 8463-8471. (Pubitemid 28471781)
5. Izsvak, Z., Ivics, Z. and Plasterk, R.H. (2000) Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J. Mol. Biol., 302, 93-102.
6. Izsvak, Z. and Ivics, Z. (2004) Sleeping beauty transposition: biology and applications for molecular therapy. Mol. Ther., 9, 147-156. (Pubitemid 38256540)
7. Galla, M., Schambach, A., Towers, G.J. and Baum, C. (2008) Cellular restriction of retrovirus particle-mediated mRNA transfer. J. Virol., 82, 3069-3077. (Pubitemid 351329195)
8. Stephen, S.L., Montini, E., Sivanandam, V.G., Al-Dhalimy, M., Kestler, H.A., Finegold, M., Grompe, M. and Kochanek, S. (2010) Chromosomal integration of adenoviral vector DNA in vivo. J. Virol., 84, 9987-9994.
9. Nightingale, S.J., Hollis, R.P., Pepper, K.A., Petersen, D., Yu, X.J., Yang, C., Bahner, I. and Kohn, D.B. (2006) Transient gene expression by nonintegrating lentiviral vectors. Mol Ther., 13, 1121-1132. (Pubitemid 43796157)
10. Wilber, A., Wangensteen, K.J., Chen, Y., Zhuo, L., Frandsen, J.L., Bell, J.B., Chen, Z.J., Ekker, S.C., McIvor, R.S. and Wang, X. (2007) Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type I. Mol. Ther., 15, 1280-1287. (Pubitemid 46965324)
11. Galla, M., Will, E., Kraunus, J., Chen, L. and Baum, C. (2004) Retroviral pseudotransduction for targeted cell manipulation. Mol. Cell, 16, 309-315. (Pubitemid 39388845)
12. Lund, A.H., Duch, M., Lovmand, J., Jorgensen, P. and Pedersen, F.S. (1997) Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer. J. Virol., 71, 1191-1195. (Pubitemid 27030291)
13. Hildinger, M., Abel, K.L., Ostertag, W. and Baum, C. (1999) Design of 5' untranslated sequences in retroviral vectors developed for medical use. J. Virol., 73, 4083-4089. (Pubitemid 29189853)
14. Philpott, N.J. and Thrasher, A.J. (2007) Use of nonintegrating lentiviral vectors for gene therapy. Hum. Gene Ther., 18, 483-489. (Pubitemid 47036043)
15. Raymond, C.S. and Soriano, P. (2007) High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS One, 2, e162.
16. Sakaue-Sawano, A., Kurokawa, H., Morimura, T., Hanyu, A., Hama, H., Osawa, H., Kashiwagi, S., Fukami, K., Miyata, T., Miyoshi, H. et al. (2008) Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell, 132, 487-498. (Pubitemid 351191996)
17. Voelkel, C., Galla, M., Maetzig, T., Warlich, E., Kuehle, J., Zychlinski, D., Bode, J., Cantz, T., Schambach, A. and Baum, C. (2010) Protein transduction from retroviral Gag precursors. Proc. Natl Acad. Sci. USA, 107, 7805-7810.
18. Maetzig, T., Galla, M., Brugman, M.H., Loew, R., Baum, C. and Schambach, A. (2010) Mechanisms controlling titer and expression of bidirectional lentiviral and gammaretroviral vectors. Gene Ther., 17, 400-411.
19. Izsvak, Z., Stuwe, E.E., Fiedler, D., Katzer, A., Jeggo, P.A. and Ivics, Z. (2004) Healing the wounds inflicted by sleeping beauty transposition by double-strand break repair in mammalian somatic cells. Mol. Cell, 13, 279-290. (Pubitemid 38183273)
20. Schambach, A., Mueller, D., Galla, M., Verstegen, M.M., Wagemaker, G., Loew, R., Baum, C. and Bohne, J. (2006) Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther., 13, 1524-1533. (Pubitemid 44567149)
21. Schambach, A., Galla, M., Maetzig, T., Loew, R. and Baum, C. (2007) Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors. Mol. Ther., 15, 1167-1173. (Pubitemid 46813620)
22. Higashimoto, T., Urbinati, F., Perumbeti, A., Jiang, G., Zarzuela, A., Chang, L.J., Kohn, D.B. and Malik, P. (2007) The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors. Gene Ther., 14, 1298-1304. (Pubitemid 47299954)
23. Hope, T. (2002) Improving the post-transcriptional aspects of lentiviral vectors. Curr. Top Microbiol. Immunol., 261, 179-189. (Pubitemid 34259343)
24. Kozak, M. (1987) An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res., 15, 8125-8148.
25. Staunstrup, N.H., Moldt, B., Mates, L., Villesen, P., Jakobsen, M., Ivics, Z., Izsvak, Z. and Mikkelsen, J.G. (2009) Hybrid lentivirus-transposon vectors with a random integration profile in human cells. Mol. Ther., 17, 1205-1214.
26. Vink, C.A., Gaspar, H.B., Gabriel, R., Schmidt, M., McIvor, R.S., Thrasher, A.J. and Qasim, W. (2009) Sleeping beauty transposition from nonintegrating lentivirus. Mol. Ther., 17, 1197-1204.
27. Izsvak, Z., Khare, D., Behlke, J., Heinemann, U., Plasterk, R.H. and Ivics, Z. (2002) Involvement of a bifunctional, paired-like DNA-binding domain and a transpositional enhancer in Sleeping Beauty transposition. J. Biol. Chem., 277, 34581-34588.
28. Scheffner, M., Munger, K., Byrne, J.C. and Howley, P.M. (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl Acad. Sci. USA, 88, 5523-5527. (Pubitemid 21914777)
29. Fehse, B., Richters, A., Putimtseva-Scharf, K., Klump, H., Li, Z., Ostertag, W., Zander, A.R. and Baum, C. (2000) CD34 splice variant: an attractive marker for selection of gene-modified cells. Mol. Ther., 1, 448-456.
30. Hosoi, T., Hyoda, K., Okuma, Y., Nomura, Y. and Ozawa, K. (2007) Akt up-and down-regulation in response to endoplasmic reticulum stress. Brain Res., 1152, 27-31. (Pubitemid 46802507)
31. Caserta, T.M., Smith, A.N., Gultice, A.D., Reedy, M.A. and Brown, T.L. (2003) Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis, 8, 345-352. (Pubitemid 36935206)
32. Leppa, S. and Bohmann, D. (1999) Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene, 18, 6158-6162.
33. Meek, D.W. (2009) Tumour suppression by p53: a role for the DNA damage response? Nature Rev. Cancer, 9, 714-723.
34. Ismail, I.H. and Hendzel, M.J. (2008) The gamma-H2AX: is it just a surrogate marker of double-strand breaks or much more. Environ. Mol. Mutagenesis, 49, 73-82. (Pubitemid 351293013)
35. Slebos, R.J. and Taylor, J.A. (2001) A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines. Biochem. Biophys. Res. Comm., 281, 212-219. (Pubitemid 32924421)
36. Teodoro, J.G., Heilman, D.W., Parker, A.E. and Green, M.R. (2004) The viral protein Apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53. Genes Dev., 18, 1952-1957. (Pubitemid 39071575)
37. Brand, K., Klocke, R., Possling, A., Paul, D. and Strauss, M. (1999) Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Ther., 6, 1054-1063. (Pubitemid 29295211)
38. Kubota, H. (2009) Quality control against misfolded proteins in the cytosol: a network for cell survival. J. Biochem., 146, 609-616.
39. Copeland, N.G. and Jenkins, N.A. (2010) Harnessing transposons for cancer gene discovery. Nat. Rev. Cancer, 10, 696-706.
40. Liang, Q., Kong, J., Stalker, J. and Bradley, A. (2009) Chromosomal mobilization and reintegration of Sleeping Beauty and PiggyBac transposons. Genesis, 47, 404-408.
41. Wilson, M.H., Coates, C.J. and George, A.L. Jr (2007) PiggyBac transposon-mediated gene transfer in human cells. Mol. Ther., 15, 139-145. (Pubitemid 46043659)
42. Miskey, C., Izsvak, Z., Plasterk, R.H. and Ivics, Z. (2003) The Frog Prince: a reconstructed transposon from Rana pipiens with high transpositional activity in vertebrate cells. Nucleic Acids Res., 31, 6873-6881. (Pubitemid 37508794)
43. Edenhofer, F. (2008) Protein transduction revisited: novel insights into the mechanism underlying intracellular delivery of proteins. Curr. Pharm. Des., 14, 3628-3636.
44. Buchholz, C.J., Muhlebach, M.D. and Cichutek, K. (2009) Lentiviral vectors with measles virus glycoproteins-dream team for gene transfer? Trends Biotechnol., 27, 259-265.